BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16263140)

  • 1. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
    Moore BB; Arenberg DA; Stoy K; Morgan T; Addison CL; Morris SB; Glass M; Wilke C; Xue YY; Sitterding S; Kunkel SL; Burdick MD; Strieter RM
    Am J Pathol; 1999 May; 154(5):1503-12. PubMed ID: 10329603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules.
    Ullah A; Zhao J; Li J; Singla RK; Shen B
    Life Sci; 2024 Jan; 336():122277. PubMed ID: 37995936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
    Gharaee-Kermani M; Kasina S; Moore BB; Thomas D; Mehra R; Macoska JA
    PLoS One; 2012; 7(11):e49278. PubMed ID: 23173053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression during capillary morphogenesis in a microcarrier-based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors.
    Sun XT; Zhang MY; Shu C; Li Q; Yan XG; Cheng N; Qiu YD; Ding YT
    World J Gastroenterol; 2005 Apr; 11(15):2283-90. PubMed ID: 15818740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.
    Salazar N; Castellan M; Shirodkar SS; Lokeshwar BL
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):77-91. PubMed ID: 23557339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
    Bao Y; Tong C; Xiong X
    Life Sci; 2024 Jul; 348():122691. PubMed ID: 38714265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
    Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment.
    Tan P; Shi M; Lai L; Tang Z; Xie N; Xu H; Wei Q; Zhang X; Yang L; Wu L
    Precis Clin Med; 2018 Jun; 1(1):49-56. PubMed ID: 35694127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL3 Signaling in the Tumor Microenvironment.
    Reyes N; Figueroa S; Tiwari R; Geliebter J
    Adv Exp Med Biol; 2021; 1302():15-24. PubMed ID: 34286438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis.
    Adekoya TO; Smith N; Thomas AJ; Lane TS; Burnette N; Rivers EJ; Li Y; Chen XL; Richardson RM
    Carcinogenesis; 2021 May; 42(5):772-783. PubMed ID: 33710266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironment.
    Yashiro M; Kinoshita H; Tsujio G; Fukuoka T; Yamamoto Y; Sera T; Sugimoto A; Nishimura S; Kushiyama S; Togano S; Kuroda K; Toyokawa T; Ohira M
    Oncol Lett; 2021 Jan; 21(1):38. PubMed ID: 33262830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells
    Liu G; An L; Zhang H; Du P; Sheng Y
    Front Pharmacol; 2019; 10():307. PubMed ID: 30984000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uev1A-Ubc13 promotes colorectal cancer metastasis through regulating
    Wu Z; Neufeld H; Torlakovic E; Xiao W
    Oncotarget; 2018 Mar; 9(22):15952-15967. PubMed ID: 29662619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells.
    Rebollo J; Geliebter J; Reyes N
    Int J Biomed Sci; 2017 Mar; 13(1):35-42. PubMed ID: 28533735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation.
    Zhang L; Zhang L; Li H; Ge C; Zhao F; Tian H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Sci Rep; 2016 Jun; 6():27426. PubMed ID: 27255419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.
    Gui SL; Teng LC; Wang SQ; Liu S; Lin YL; Zhao XL; Liu L; Sui HY; Yang Y; Liang LC; Wang ML; Li XY; Cao Y; Li FY; Wang WQ
    Int Urol Nephrol; 2016 May; 48(5):701-9. PubMed ID: 26837773
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.